|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 Instructor, Department of Medicine, Tulane Medical School, New Orleans, Louisiana.
2 Visiting Physician, Charity Hospital of Louisiana at New Orleans, Louisiana.
1. A six year series of tuberculosis patients receiving pneumoperitoneum was reviewed and 90 cases were analyzed. Pneumoperitoneum was used alone, with phrenemphraxis and with antibacterial drugs.
2. The lesions were predominantly exudative, far-advanced, bilateral cavitary and in the upper one third of the lung.
3. Pneumoperitoneum proved to be of definite value with regard to cavity closure and its therapeutic effectiveness was enhanced by antibiotics (streptomycin and sodium para-aminosalicylate).
4. Response to therapy was usually evident by the ninth month of pneumoperitoneum, and this should be the minimum duration of therapy once begun.
5. Complications from pneumoperitoneum are few; ascites and abdominal discomfort occasionally caused the procedure to be discontinued.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |